| P2093 | author name string | Lipinski B | |
| P2860 | cites work | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| | Chemokines and leukocyte traffic | Q29618886 |
| | Protein oxidation in aging, disease, and oxidative stress | Q29619442 |
| | Thiol-based antioxidants. | Q30326876 |
| | Vitamin E and vascular homeostasis: implications for atherosclerosis | Q33640400 |
| | Antioxidant defenses and lipid peroxidation in human blood plasma | Q33688237 |
| | Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E. | Q33712857 |
| | Nitric oxide and its role in lipid peroxidation. | Q33737753 |
| | Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials | Q33793020 |
| | Antioxidants, NFkappaB activation, and diabetogenesis | Q33796820 |
| | Radicals and oxidative stress in diabetes | Q33900538 |
| | Oxidative stress and cardiac disease | Q34038724 |
| | Minimally modified low density lipoprotein stimulates monocyte endothelial interactions | Q34248823 |
| | The pharmacology of the antioxidant lipoic acid | Q34447239 |
| | Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 |
| | The role of lipid peroxidation and antioxidants in oxidative modification of LDL. | Q35379559 |
| | Distinctive role of histidine-16 of the B beta chain of fibrinogen in the end-to-end association of fibrin | Q35587916 |
| | Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis | Q36375915 |
| | The measurement and mechanism of lipid peroxidation in biological systems | Q37923154 |
| | Role of oxidatively modified LDL in atherosclerosis | Q37978587 |
| | Fibrinogen as a major risk factor in cardiovascular disease | Q38016977 |
| | Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy | Q39540319 |
| | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects | Q40795448 |
| | Aged garlic extract attenuates intracellular oxidative stress | Q40947317 |
| | Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy | Q73403584 |
| | Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer | Q73514241 |
| | Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood | Q73515197 |
| | Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies | Q73626218 |
| | Coronary heart disease in patients with diabetes | Q73631285 |
| | Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy | Q73712824 |
| | Metal-ion catalyzed oxidation affects fibrinogen activity on platelet aggregation and adhesion | Q73833919 |
| | The biological significance of fibrinolysis | Q74260276 |
| | Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes | Q74319408 |
| | Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection | Q74642435 |
| | Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients | Q77164597 |
| | Adsorption of fibrinogen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications | Q77666178 |
| | Structure and stability of the dityrosine-linked dimer of gammaB-crystallin | Q77901387 |
| | The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy | Q77944235 |
| | alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria | Q77988248 |
| | Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications | Q78163788 |
| | Inflammation enhances cardiovascular risk and mortality in hemodialysis patients | Q78163875 |
| | Thrombosis as a factor in the pathogenesis of coronary atherosclerosis | Q82176732 |
| | Fibrinogen coagulation without thrombin: reaction with vitamin C and copper(II) | Q93678880 |
| | Antioxidants, atherosclerosis and thrombosis. | Q41154173 |
| | Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein | Q41167595 |
| | Fibrinogen and diabetes mellitus: is it time for intervention trials? | Q41531053 |
| | Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease | Q41693341 |
| | Oxidative stress in families of type 1 diabetic patients | Q42491808 |
| | Structural modifications of human β2 microglobulin treated with oxygen-derived radicals | Q42862003 |
| | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 |
| | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. | Q44431760 |
| | Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: Pathogenetic differences | Q45938572 |
| | Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion. | Q45971058 |
| | Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis | Q46491713 |
| | Body mass index, diabetes, and C-reactive protein among U.S. adults | Q46780760 |
| | Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. | Q50892131 |
| | The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. | Q51019649 |
| | Plasma fibrinogen in NIDDM: the Rotterdam study. | Q51021585 |
| | In vitro and in vivo antioxidant properties of gliclazide. | Q51553487 |
| | Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. | Q51557740 |
| | Direct observation of fibrinogen-heparinoid complexes formation using surface plasmon resonance. | Q51604973 |
| | Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. | Q52432373 |
| | Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients. | Q53816202 |
| | Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. | Q54071317 |
| | Inhibition of Thrombin and of Fibrin Polymerization, Two Activities derived from Plasmin-digested Fibrinogen | Q58964924 |
| | Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. | Q64927766 |
| | Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes | Q67574961 |
| | Identified diallyl polysulfides from an aged garlic extract which protects the membranes from lipid peroxidation | Q67972233 |
| | Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima | Q68110135 |
| | Glomerular deposition of cross-linked fibrin in human kidney diseases | Q68183281 |
| | Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease | Q68502564 |
| | The organ distribution of 125I-fibrin in the generalized Shwartzman reaction and its relation to leucocytes | Q68837607 |
| | Neutrophil function in ischemic heart disease | Q69329605 |
| | Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V | Q70220095 |
| | Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis | Q70642109 |
| | RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus | Q71043725 |
| | Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 |
| | Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome | Q71524484 |
| | Increased low density lipoprotein oxidation in stable kidney transplant recipients | Q71568706 |
| | Impaired fibrinolysis and the risk for coronary heart disease | Q71745406 |
| | Oxidation of low density lipoproteins from patients with renal failure or renal transplants | Q71754583 |
| | Protein oxidation in hemodialysis and kidney transplantation | Q71807974 |
| | Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima | Q71984907 |
| | Plasma macromolecular protein complex: Interaction with fibrin and fibrinolysis | Q72024131 |
| | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors | Q72049303 |
| | Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits | Q72102989 |
| | Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation | Q72238077 |
| | Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study | Q72369100 |
| | Inflammation and diabetic vascular complications | Q73249157 |
| | Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes | Q73249239 |
| | Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin | Q73295921 |
| | Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy | Q73333470 |
| P433 | issue | 4 | |
| P921 | main subject | oxidative stress | Q898814 |
| | pathophysiology | Q1135939 |
| P304 | page(s) | 203-210 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of Diabetes and its Complications | Q15763696 |
| P1476 | title | Pathophysiology of oxidative stress in diabetes mellitus | |
| P478 | volume | 15 | |